Asunto(s)
Carcinoma de Células Escamosas/diagnóstico , Neoplasias Cutáneas/diagnóstico , Anciano , Brazo , Enfermedad de Bowen/complicaciones , Enfermedad de Bowen/diagnóstico , Carcinoma de Células Escamosas/complicaciones , Carcinoma de Células Escamosas/patología , Codo , Antebrazo , Rechazo de Injerto/prevención & control , Humanos , Inmunosupresores/uso terapéutico , Trasplante de Riñón , Masculino , Tomografía Computarizada por Tomografía de Emisión de Positrones , Infecciones por Pseudomonas/complicaciones , Infecciones por Pseudomonas/diagnóstico , Infecciones por Serratia/complicaciones , Infecciones por Serratia/diagnóstico , Enfermedades Cutáneas Bacterianas/complicaciones , Enfermedades Cutáneas Bacterianas/diagnóstico , Neoplasias Cutáneas/complicaciones , Neoplasias Cutáneas/patología , Infecciones Cutáneas Estafilocócicas/complicaciones , Infecciones Cutáneas Estafilocócicas/diagnóstico , Carga TumoralRESUMEN
Allergic contact dermatitis (ACD) secondary to acrylates and methacrylates is a well- described occurrence, particularly in those who wear or handle gel nail varnish. Management involves avoidance of the identified allergen. The cause of chronic urticaria (CI) is often not identified, and CU is not known to be associated with acrylates or methacrylates. We report a case of a 50-year-old woman who initially presented with hand dermatitis exacerbated by gel nail varnish on a background of CU. Avoiding all nail varnishes because of her ACD also resulted in improvement of her CU. To our knowledge, this is the first documented case of CU secondary to the acrylates and methacrylates found in nail cosmetics.
Asunto(s)
Acrilatos/efectos adversos , Cosméticos/efectos adversos , Dermatitis Alérgica por Contacto/etiología , Dermatosis de la Mano/inducido químicamente , Metacrilatos/efectos adversos , Urticaria/inducido químicamente , Enfermedad Crónica , Femenino , Humanos , Persona de Mediana Edad , Uñas , Tiazoles/efectos adversosRESUMEN
Systemic AL amyloidosis is known to be associated with plasma cell dyscrasias, including multiple myeloma. The cutaneous manifestations of systemic AL amyloidosis are varied, but typically include waxy plaques or subcutaneous nodules. We report a woman who presented with bilateral eruptions of hyperpigmented plaques in her axillae, which were diagnosed as milia en plaque. She had a history of multiple myeloma, for which she was under the care of a haematologist. This is the first documented case, to our knowledge, of an eruption in the axillae being milia en plaque.